Reinforcing the supply chain of umifenovir and other antiviral drugs with retrosynthetic software
COVID-19 has exposed the fragility of supply chains, particularly for goods that are essential or may suddenly become essential, such as repurposed pharmaceuticals. Here the authors develop a methodology to provide routes to pharmaceutical targets that allow low-supply starting materials or intermed...
保存先:
| 主要な著者: | , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Portfolio
2021-12-01
|
| シリーズ: | Nature Communications |
| オンライン･アクセス: | https://doi.org/10.1038/s41467-021-27547-3 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|